12933_2019_977_MOESM5_ESM.doc (65.5 kB)
MOESM5 of Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
journal contribution
posted on 2020-01-08, 04:55 authored by Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, Yosuke Okada, Takamasa Ichijo, Mariko Higa, Toru Hiyoshi, Ikuo Inoue, Kaoru Iso, Hidenori Yoshii, Takahisa Hirose, Naoki KumashiroAdditional file 5: Table S4. Adverse events.